Purpose of the study to know the action of phalendradi yogam with and without yashada bhasma in madhumeha(diabetes)

Phase 1/2

Recruiting

• Conditions: Type 2 Diabetes Mellitus

• Registration Number: CTRI/2015/03/005660
• Lead Sponsor: Dr BRKR Govt Ayurvedic College

Brief Summary

Diabetes is global epedemic according to WHO reports India tops the world capital for Diabetes. By 2025 approximately 55 million Indians will be affected by Diabetes.

Knowledge of Madhumeha is available since vedic period itself. Madhumeha finds its clear mentioning in the ancient books of Charaka Samhitha, Susrutha Samhitha, Astangahridaya, and Bavaprakasha.



Despite the introduction of hypoglycemic agents from natural and synthetic sources, diabetes and its secondary complications continue to be a major medical problem.Many indigenous Indian medicinal plants have been found to be useful to sucessfully manage diabetes.One of the great advantage of medicinal plants is that these are readily available and have no side effects World Health Organisation(WHO) has suggested the evaluation of the potential of the plants as effective therapeutic agents,especially in areas in which we lack of safe modern drugs.

The "PHALENDRADI YOGAM" will contain

1.Phalendra                                                            Syzygium Cumini                      (Seeds)

2.Mesha shrungi                                                Gymnema sylvestre                     (Leaf)

3.Haridra                                                              Curcum olonga                            (Rhizome)

4.Amlaki                                                               Emblica officinails                        (Fruit)

5.Kalamegh                                                        Andrographis Panniculata           (Whole Plant)

6.Yashada Bhasma                                                                                                    (Zinc oxide(zno))

However,there is no comprehensive analysis and this drugs have not been scientifically validated in the treatment of madhumeha thats why i have taken for the study.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01-08
• Last Update Posted: 2015-03-19

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1)Subjectsbetween the age of 30-60 years 2) Subjects suffering with DM type 2 3) Subjects intrested in treatment for Diabetes.

Exclusion Criteria

Who are suffering with madumeha more than 10 years Madhumeha with other serious complications Serum creatinine >1.5 albuminurea > 40 Ug/min.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood sugar levels will be in normal limits	Within 90 days

Secondary Outcome Measures

Name	Time	Method
Improved quality of life and blood sugar levels will be in normal levels	Within 90 days

Trial Locations

Locations (1)

Department of Kayachikitsa, Room no 3; 🇮🇳 Hyderabad, ANDHRA PRADESH, India

Department of Kayachikitsa, Room no 3

🇮🇳Hyderabad, ANDHRA PRADESH, India

DR UMASRINIVAS RAO NEREDU

Principal investigator

9246366104

dr.nusrao@yahoo.in